Brown Brothers Harriman & Co. Has $1.64 Million Position in iShares Biotechnology ETF (NASDAQ:IBB)

Brown Brothers Harriman & Co. increased its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 40,000.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,228 shares of the financial services provider’s stock after buying an additional 11,200 shares during the quarter. Brown Brothers Harriman & Co.’s holdings in iShares Biotechnology ETF were worth $1,635,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Williams Financial LLC acquired a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at about $867,000. PVG Asset Management Corp bought a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at approximately $415,000. Huntington National Bank raised its holdings in shares of iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after buying an additional 160 shares in the last quarter. Concourse Financial Group Securities Inc. lifted its position in shares of iShares Biotechnology ETF by 22.4% during the 2nd quarter. Concourse Financial Group Securities Inc. now owns 656 shares of the financial services provider’s stock worth $90,000 after buying an additional 120 shares during the period. Finally, Raymond James & Associates raised its stake in iShares Biotechnology ETF by 4.4% during the second quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock worth $26,047,000 after acquiring an additional 7,931 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $139.91 on Tuesday. The company’s fifty day moving average is $143.27 and its 200-day moving average is $141.92. iShares Biotechnology ETF has a 52 week low of $117.28 and a 52 week high of $150.57.

iShares Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.